Data supporting the findings of this study. by Aga E. Gelgie (17661720)

“…In comparison to the parent strain, the 0690::Tn mutant displayed markedly reduced fitness, as evidenced by a significant decrease or even absence in post-challenge mycoplasma counts in murine and cow mammary tissues, respectively. …”

<i>M</i>. <i>bovis</i> 0690::Tn mutant failed to elicit the recruitment of neutrophils into milk spaces. by Aga E. Gelgie (17661720)

Baseline demographic characteristics. by Jung-Tae Kim (8997767)

“…Group 2 exhibited a significantly greater decrease in GCC thickness compared with Group 1(P = 0.026).…”

I Optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

ANOVA for I optimal design of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

The kinetic release data of the optimized formula compared to drug suspension. by Randa Mohammed Zaki (21637175)

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. by Randa Mohammed Zaki (21637175)

Mapping of transposon insertions in the selected mutants of <i>M</i>. <i>bovis</i> PG45. by Aga E. Gelgie (17661720)

Difference in proportion of lesions correctly identified by young and old cohort of optometrists (A) Performance of subjects with normal color vision. by Richard C. Trevino (22676460)

PIF4 protein level regulates <i>PIF4</i> promoter activity in a temperature-dependent manner. by Sreya Das (20531295)

S1 File - Climate change and its impact on wheat distribution in semi-arid ecosystems: A case study from the Sultanate of Oman by Khalifa M. Al-Kindi (3719854)

Multi-strain model fitting based on data for influenza A and B cases from the 40th week of 2023 to the 17th week of 2024 in the United States. by Shuanglin Jing (11886368)

a. Positive ion multi-dimensional analysis chart (A) Mild PTOA group VS Severe PTOA group (B) Mild PTOA group VS normal group (C) Severe PTOA group VS Normal group (a) 3D PCA score... by Peng-fei Han (694841)

<b>Collapsin response mediator protein 2 modulates synaptic function by stabilizing the surface expression of phosphorylated AMPA receptor GluA2 subunits</b> by ren (21408623)

“…Upon phorbol myristate acetate (TPA) induced activation of protein kinase C (PKC), the surface expression of GluA2 decreased significantly, as phosphorylation of GluA2 at the S880 site is known to promote its internalization. …”

Data Sheet 2_The association between glycated hemoglobin, physical activity and infertility: a multiple logistic regression and mediation analysis based on the NHANES database.pdf by Panpan Chen (307628)

“…Furthermore, the mediation analysis revealed that recreational PA did not have a statistically significant direct effect on infertility (p = 0.098). …”

Data Sheet 1_The association between glycated hemoglobin, physical activity and infertility: a multiple logistic regression and mediation analysis based on the NHANES database.pdf by Panpan Chen (307628)

“…Furthermore, the mediation analysis revealed that recreational PA did not have a statistically significant direct effect on infertility (p = 0.098). …”

Neuroprotective effects of Cannabidiol in 5XFAD Mice: Reducing amyloid and tau burden in the dorsal subiculum by Muhammad Kamal Hossain (19814445)

“…Interpretation:</b> Our results showed that CBD treatment led to a significant reduction in Aβ accumulation and a marked decrease in hyperphosphorylated tau in treated mice compared to controls. …”

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”